Half of LatAm doctors interested in face to face pharma reps visits

A large-scale survey just released by Fine Research shows that half of LatAm doctors are open to receiving in-person pharma rep visits now, while 9 out of 10 would be happy to return to this approach once the pandemic is fully controlled.

The full data is now available to download in the report ‘The new landscape for HCPs in Latin America’.

By reading this report you will learn:

  • How the pandemic has profoundly transformed the medical practice and doctors’ interactions with the pharma industry
  • Emerging trends and how these vary between different countries and medical specialties
  • Practical insight to help you prepare for the future of pharma-HCP interactions

Download your copy of the must-read report here.

Since March, Fine Research has been running this influential research tracking project around the impact of COVID-19, including over 11,000 interviews with HCPs in 15 different countries across LatAm. 

Thank you to Diego CasaravillaCEO of Fine Research for sharing this insightful report with us. For more information contact him on info@fine-research.com

Best wishes,

Lucy Muñiz
Editor The Pharmaceutical Marketing Group